[Febrile syndrome in children younger than 29 days]

Benigno M Méndez Espinola1, Patricio Herrera Labarca1

  • 1Hospital Roberto del Río, Santiago, Chile.

Insights

Fever of unknown origin (FUO) in newborns poses a risk of serious bacterial infection (SBI). While most infants show mild symptoms, 24% have SBI, necessitating hospitalization and careful monitoring. Standard lab tests are poor predictors of SBI.

Area of Science:

  • Neonatal Medicine
  • Pediatric Infectious Diseases
  • Clinical Diagnostics

Background:

  • Acute fever of unknown origin (FUO) in neonates (<29 days) is a significant concern due to the potential for serious bacterial infection (SBI).
  • Prompt diagnosis and management are crucial for improving outcomes in febrile newborns.

Purpose of the Study:

  • To investigate the clinical and laboratory characteristics of hospitalized neonates diagnosed with FUO.
  • To assess the predictive value of laboratory markers for SBI in this population.

Main Methods:

  • Retrospective study of 468 neonates (<29 days) hospitalized with FUO.
  • Analysis of clinical records, including fever history, admission temperature, severity assessment, diagnoses, laboratory tests, and treatments.
  • Classification of patients into severe (S) and non-severe (NS) groups based on discharge diagnosis.

Main Results:

  • Urinary tract infection was the predominant diagnosis in the severe group (70.5%), while FUO was most common in the non-severe group (67.6%).
  • Low concordance was observed between admission and discharge severity assessments.
  • Leukocyte count, C-reactive protein (CRP), and neutrophil counts demonstrated low negative predictive values for ruling out SBI.

Conclusions:

  • Despite most neonates presenting with mild initial severity, a significant proportion (24%) had SBI, underscoring the need for hospitalization and close observation.
  • Routine laboratory tests like CRP and white blood cell counts are unreliable predictors of SBI in febrile newborns.
  • The early administration of antibiotics for low-risk infants with FUO remains a debatable clinical decision.
Abstract

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
5.5K
Types of Fever01:25

Types of Fever

Fever can be triggered by several factors, including infections, nervous system disorders, certain cancers, blood diseases like leukemia, embolism, thrombosis, heatstroke, dehydration, surgical trauma, crushing injuries, and allergic reactions.
Here are the different types of fever:
740
Patterns of Fever01:26

Patterns of Fever

Before understanding the types and patterns of fever, it is essential to know its phases.
3.2K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
926
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
2.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68